Navigation Links
Genta Incorporated to Present Multiple Abstracts at the Annual,Meeting of the American Society of Clinical Oncology

BERKELEY HEIGHTS, N.J., May 25, 2007 /PRNewswire-FirstCall/ -- Genta Incorporated announced that several abstracts featuring its oncology products, Genasense(R) (oblimersen sodium) Injection, and Ganite(R) (gallium nitrate injection), will be presented at the 43rd annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 1-5, 2007. The abstracts include the following:

    -- LDH is a Prognostic Factor in Stage IV Melanoma Patients but is a

       Predictive Factor only for Bcl-2 Antisense Treatment Efficacy: Re-

       analysis of GM301 and EORTC18951 Randomized Trials.  Abstract #8552;

       Sunday, June 3, 2007.

    -- A Phase III Randomized Trial of Intensive Induction and Consolidation

       Chemotherapy +/- Oblimersen (Genasense; G3139), a Pro-Apoptotic Bcl-2

       Antisense Oligonucleotide, in Untreated Acute Myeloid Leukemia Patients

       greater than or equal to 60 Years Old: Cancer and Leukemia Group B

       (CALGB) Study 10201. Abstract #7012; Saturday, June 2, 2007.

    -- GaRD Study: Gallium, Rituximab, and Dexamethasone for Relapsed NHL.

       Poster #Y1, Abstract #8079; Saturday, June 2, 2007.

    -- Oblimersen (Genasense(R)) Can Be Administered by Subcutaneous and Brief

       Intravenous Infusion: Clinical Pharmacokinetics and Pharmacodynamics in

       Patients with Advanced Cancer. (Publication)

    -- Long-term Administration of Oblimersen plus Chemotherapy: An Analysis

       of Safety in Patients with Solid Tumors and Hematologic Cancers.

       (Publication)

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblim
'"/>




Page: 1 2 3

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:6/30/2015)... MIRAMAR BEACH, Fla. , June 30, 2015  July ... our country,s declaration of independence, and the spirit and people ... For Heroes Foundation has partnered with USA ... cards, to help increase funding for programs that empower independence ... across the country, and help more people afford their prescriptions. ...
(Date:6/30/2015)... 2015  Marken, the leading clinical trial logistics organization ... has been granted permission by the government to deliver ... product in Korea.  This precedent-setting shipment has allowed several ... continue receiving their clinical trial drugs during the outbreak ... emergency was caused by recent partial closures of medical ...
(Date:6/30/2015)... -- Legal-Bay LLC, the Lawsuit Settlement Funding Company, announced ... litigation (MDL) over the Zimmer NexGen Knee implant lawsuits ... 2015. There are currently more than a thousand cases ... federal judge in Illinois . The ... in October of this year. Zimmer Inc. previously issued ...
Breaking Medicine Technology:Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3
... ROCKVILLE, Md., Feb. 18, 2011 Novavax, Inc. ... today presented the final safety and immunogenicity results from ... clinical trial in Mexico at the invitation-only 7th World ... Vaccines in Clinical Trials. The meeting was held at ...
... Feb. 18, 2011 FUJIFILM Medical Systems ... footprint mobile application enabling remote access to ... as well as Macintosh- or Windows-based PCs.  Differentiated from ... quality, interactive three dimensional medical images in any platform ...
Cached Medicine Technology:NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 2NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 3NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 4NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 5Fujifilm's Synapse® Mobility Extends Imaging Reach 2
(Date:7/1/2015)... ... July 01, 2015 , ... ... and devices, today announced the opening of a new operational office in Zurich, ... that enables collaboration across all lines of business for organizations throughout the Swiss ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Nutritional Products International, ... nutritional and beauty products, recently attended the 2015 ECRM Diet, Vitamin & Sports Nutrition ... the retail industry. The ECRM trade show allows companies the chance to ...
(Date:7/1/2015)... ... July 01, 2015 , ... RF Technologies, ... has partnered with WIU Crossroads School in safeguarding its staff and students with ... Education for Disruptive Youth) environment of Crossroads School heightens the potential for disorderly ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Foot ... Friske ( Clarksville Division ) participated in the annual Howard County Family Wellness Day ... promote healthy lifestyles, and included wellness screenings, activities for children, free workout demonstrations, and ...
(Date:7/1/2015)... ... July 01, 2015 , ... First ... created a web-based resource where legal cannabis startups can interact with ... entrepreneurs and medical marijuana advocates looking to strategically enter and capitalize on growing ...
Breaking Medicine News(10 mins):Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3Health News:NPI Meets With Top Retail Figures at ECRM Conference 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 3Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 3Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 3
... of the time childhood acute lymphoblastic leukemia is curable with ... // why it doesn’t work for the other 20 percent ... of a small number of genes that are resistant to ... leukemia cells from 173 children. They looked at the sensitivity ...
... is the leading cause of irreversible vision loss in ... that could be involved with this disease. The discovery ... this disease. ,Researchers collected blood samples from 402 ... was examined for variations in genes that code for ...
... a diet high in fiber from fruit and soy ... -- especially cough with phlegm.// ,Researchers studied ... and more than 44,000 patients without the respiratory problem. ... if certain foods were associated with a reduced risk ...
... help ward off heart disease .Researchers analyzed the role ... thought to play a part in heart disease. ... not find enough evidence in the studies to recommend ... or strokes. Instead, researchers suggest eating a diet rich ...
... risk of bone fractures among kids who take inhaled ... recommend inhaled steroids as the first line of defense ... doctors have long worried these drugs might be weakening ... stems from research showing a link between oral forms ...
... good reason not to smoke. According to a recent study ... increases the risk of having a baby with a cleft ... who were interviewed when their babies were about six months ... during pregnancy, including how many cigarettes she smoked and whether ...
Cached Medicine News:
... low density lipoprotein cholesterol (LDL-C) ... stable, ready-to-use reagent. Selective direct ... Excellent correlation with established reference ... Available with Calibrator: Trucal HDL/LDL ...
Storage temperature: 2 - 8C, linearity: 0 - 25 mg/dL, expected value: 3.5 - 7.0 mg/dL. Available with calibrator and number of test 125....
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
For the quantitative determination of uric acid in serum....
Medicine Products: